TY - JOUR
T1 - A Biodegradable “One-For-All” Nanoparticle for Multimodality Imaging and Enhanced Photothermal Treatment of Breast Cancer
AU - Hsu, Jessica C.
AU - Barragan, Diego
AU - Tward, Alexander E.
AU - Hajfathalian, Maryam
AU - Amirshaghaghi, Ahmad
AU - Mossburg, Katherine J.
AU - Rosario-Berríos, Derick N.
AU - Bouché, Mathilde
AU - Andrianov, Alexander K.
AU - Delikatny, Edward J.
AU - Cormode, David P.
N1 - Publisher Copyright:
© 2023 Wiley-VCH GmbH.
PY - 2024/3/25
Y1 - 2024/3/25
N2 - Silver sulfide nanoparticles (Ag2S-NP) hold promise for various optical-based biomedical applications, such as near-infrared fluorescence (NIRF) imaging, photoacoustics (PA), and photothermal therapy (PTT). However, their NIR absorbance is relatively low, and previous formulations are synthesized using toxic precursors under harsh conditions and are not effectively cleared due to their large size. Herein, sub-5 nm Ag2S-NP are synthesized and encapsulated in biodegradable, polymeric nanoparticles (AgPCPP). All syntheses are conducted using biocompatible, aqueous reagents under ambient conditions. The encapsulation of Ag2S-NP in polymeric nanospheres greatly increases their NIR absorbance, resulting in enhanced optical imaging and PTT effects. AgPCPP nanoparticles exhibit potent contrast properties suitable for PA and NIRF imaging, as well as for computed tomography (CT). Furthermore, AgPCPP nanoparticles readily improve the conspicuity of breast tumors in vivo. Under NIR laser irradiation, AgPCPP nanoparticles significantly reduce breast tumor growth, leading to prolonged survival compared to free Ag2S-NP. Over time, AgPCPP retention in tissues gradually decreases, without any signs of acute toxicity, providing strong evidence of their safety and biodegradability. Therefore, AgPCPP may serve as a “one-for-all” theranostic agent that degrades into small components for excretion after fulfilling diagnostic and therapeutic tasks, offering good prospects for clinical translation.
AB - Silver sulfide nanoparticles (Ag2S-NP) hold promise for various optical-based biomedical applications, such as near-infrared fluorescence (NIRF) imaging, photoacoustics (PA), and photothermal therapy (PTT). However, their NIR absorbance is relatively low, and previous formulations are synthesized using toxic precursors under harsh conditions and are not effectively cleared due to their large size. Herein, sub-5 nm Ag2S-NP are synthesized and encapsulated in biodegradable, polymeric nanoparticles (AgPCPP). All syntheses are conducted using biocompatible, aqueous reagents under ambient conditions. The encapsulation of Ag2S-NP in polymeric nanospheres greatly increases their NIR absorbance, resulting in enhanced optical imaging and PTT effects. AgPCPP nanoparticles exhibit potent contrast properties suitable for PA and NIRF imaging, as well as for computed tomography (CT). Furthermore, AgPCPP nanoparticles readily improve the conspicuity of breast tumors in vivo. Under NIR laser irradiation, AgPCPP nanoparticles significantly reduce breast tumor growth, leading to prolonged survival compared to free Ag2S-NP. Over time, AgPCPP retention in tissues gradually decreases, without any signs of acute toxicity, providing strong evidence of their safety and biodegradability. Therefore, AgPCPP may serve as a “one-for-all” theranostic agent that degrades into small components for excretion after fulfilling diagnostic and therapeutic tasks, offering good prospects for clinical translation.
KW - multimodality imaging
KW - nanoparticles
KW - photothermal therapy
KW - polyphosphazene
KW - silver sulfide
UR - http://www.scopus.com/inward/record.url?scp=85180424116&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85180424116&partnerID=8YFLogxK
U2 - 10.1002/adhm.202303018
DO - 10.1002/adhm.202303018
M3 - Article
C2 - 38117252
AN - SCOPUS:85180424116
SN - 2192-2640
VL - 13
JO - Advanced Healthcare Materials
JF - Advanced Healthcare Materials
IS - 8
M1 - 2303018
ER -